KERRI HOLLOWAY: Open Payments
NPI 1396216123 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 36 payments from 21 companies in 2025. Trend: 2023 $753 · 2024 $815 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $79 |
| PFIZER INC. | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 4 | $68 |
| Eisai Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Celgene Corporation | 2 | $49 |
| TAIHO ONCOLOGY, INC. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
Products named: Lenvima, ELAHERE, PLUVICTO, REBLOZYL, LONSURF, ENHERTU, Padcev, OPDIVO.
Industry payments across GA — which companies pay providers there.
